Johnson & Johnson (JNJ) to Withdraw the LINC Reflux Management System from Markets Outside the U.S.

With significant upside potential, Johnson & Johnson (NYSE:JNJ) secures a spot on our list of the 13 Best Diversified Stocks to Buy According to Hedge Funds. Johnson & Johnson (JNJ) to Withdraw the LINC Reflux Management System from Markets Outside the U.S. Trong Nguyen / Shutterstock.com On September 23, 2025, Johnson & Johnson (NYSE:JNJ) announced that it will withdraw the LINC Reflux Management System from markets outside the U.S. by the end of March 2026 for commercial reasons. The LINC Reflux Manag ...